These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34358858)

  • 1. Reduced anaphylactic potential of denatured pullulan-conjugated Cry j 1.
    Utsumi D; Sugawara T; Hashida K; Yasuhara Y; Fujinami K; Lund K; Ohashi-Doi K
    Int Immunopharmacol; 2021 Oct; 99():108026. PubMed ID: 34358858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of rice seed-based oral allergy vaccine for Japanese cedar pollinosis in Japanese monkeys.
    Saito S; Takagi H; Wakasa Y; Ozawa K; Takaiwa F
    Mol Immunol; 2020 Sep; 125():63-69. PubMed ID: 32650161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
    Osada T; Tanaka Y; Yamada A; Sasaki E; Utsugi T
    Allergol Int; 2018 Oct; 67(4):467-474. PubMed ID: 29525489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys.
    Fujimura T; Fujinami K; Ishikawa R; Tateno M; Tahara Y; Okumura Y; Ohta H; Miyazaki H; Taniguchi M
    Int Arch Allergy Immunol; 2015; 168(1):32-43. PubMed ID: 26524293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Masuda K
    Vet Immunol Immunopathol; 2005 Oct; 108(1-2):185-7. PubMed ID: 16098609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.
    Wakasa Y; Takagi H; Hirose S; Yang L; Saeki M; Nishimura T; Kaminuma O; Hiroi T; Takaiwa F
    Plant Biotechnol J; 2013 Jan; 11(1):66-76. PubMed ID: 23066780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-reactivity between major IgE core epitopes on Cry j 2 allergen of Japanese cedar pollen and relevant sequences on Cha o 2 allergen of Japanese cypress pollen.
    Miyaji K; Okamoto N; Saito A; Yasueda H; Takase Y; Shimakura H; Saito S; Sakaguchi M
    Allergol Int; 2016 Jul; 65(3):286-92. PubMed ID: 26916996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of IgE-Allergen-CD23 Complex Changes in Children Treated with Subcutaneous Immunotherapy for Japanese Cedar Pollinosis.
    Asaumi T; Sato S; Yanagida N; Matsuhara H; Kobayashi S; Fukano C; Ohashi-Doi K; Ebisawa M
    Int Arch Allergy Immunol; 2021; 182(3):190-194. PubMed ID: 33032294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of enzyme-linked immunosorbent facilitated antigen binding as a biomarker assay for Japanese cedar pollen allergy immunotherapy.
    Fukano C; Ohashi-Doi K; Lund K; Nakao A; Masuyama K; Matsuoka T
    J Pharmacol Sci; 2019 Jul; 140(3):223-227. PubMed ID: 31353210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell activation by transgenic rice seeds expressing the genetically modified Japanese cedar pollen allergens.
    Takaishi S; Saito S; Endo T; Asaka D; Wakasa Y; Takagi H; Ozawa K; Takaiwa F; Otori N; Kojima H
    Immunology; 2019 Oct; 158(2):94-103. PubMed ID: 31323138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-allergic potential of oligomannose-coated liposome-entrapped Cry j 1 as immunotherapy for Japanese cedar pollinosis in mice.
    Ishii M; Koyama A; Iseki H; Narumi H; Yokoyama N; Kojima N
    Int Immunopharmacol; 2010 Sep; 10(9):1041-6. PubMed ID: 20584630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological and Symptomatic Effects of Oral Intake of Transgenic Rice Containing 7 Linked Major T-Cell Epitopes from Japanese Cedar Pollen Allergens.
    Endo T; Asaka D; Nakayama T; Saito S; Kodama H; Mitsuyoshi R; Takaishi S; Sugimoto N; Omae S; Takagi H; Wakasa Y; Ozawa K; Takano M; Takaiwa F; Kojima H; Saito S
    Int Arch Allergy Immunol; 2021; 182(2):109-119. PubMed ID: 32854094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II study of oral immunotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis.
    Murakami D; Kubo K; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Auris Nasus Larynx; 2014 Aug; 41(4):350-8. PubMed ID: 24698163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.
    Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Allergol Int; 2015 Apr; 64(2):161-8. PubMed ID: 25838092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy.
    Fujimura T; Kawamoto S
    Allergol Int; 2015 Oct; 64(4):312-20. PubMed ID: 26433527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentrated protein body product derived from rice endosperm as an oral tolerogen for allergen-specific immunotherapy--a new mucosal vaccine formulation against Japanese cedar pollen allergy.
    Wakasa Y; Takagi H; Watanabe N; Kitamura N; Fujiwara Y; Ogo Y; Hayashi S; Yang L; Ohta M; Thet Tin WW; Sekikawa K; Takano M; Ozawa K; Hiroi T; Takaiwa F
    PLoS One; 2015; 10(3):e0120209. PubMed ID: 25774686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Cry-consensus peptide, a novel recombinant peptide for immunotherapy of Japanese cedar pollinosis, on an experimental allergic rhinitis model in B10.S mice.
    Tsunematsu M; Yamaji T; Kozutsumi D; Murakami R; Kimura S; Kino K
    Allergol Int; 2007 Dec; 56(4):465-72. PubMed ID: 17965586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of an Allergen-Antibody Reaction Related to Japanese Cedar Pollinosis Using DNA Aptamers Against the Cry j 2 Allergen.
    Ogihara K; Savory N; Abe K; Yoshida W; Arakawa M; Asahi M; Kamohara S; Ikebukuro K
    Nucleic Acid Ther; 2015 Dec; 25(6):311-6. PubMed ID: 26484654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety evaluation of standardized allergen extract of Japanese cedar pollen for sublingual immunotherapy.
    Mitobe Y; Yokomoto Y; Ohashi-Doi K
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):529-40. PubMed ID: 25701184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: candidate for peptide-based immunotherapy of Japanese cedar pollinosis.
    Masuyama K; Chikamatsu K; Ikagawa S; Matsuoka T; Takahashi G; Yamamoto T; Endo S
    Allergol Int; 2009 Mar; 58(1):63-70. PubMed ID: 19050376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.